Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Bray
Mark Buller

Showing results (31-40 of 134) with videos related to

Pageof 14
Sort By:
Antiviral Research|March 5, 2003
Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infectionsRobert O Baker, Mike Bray, John W Huggins
Viruses|November 22, 2012
Mouse models for filovirus infectionsSteven B Bradfute, Kelly L Warfield, Mike Bray
Future Virology|September 4, 2009
Therapeutic and prophylactic drugs to treat orthopoxvirus infectionsScott Parker, Lauren Handley, R Mark Buller
Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science|July 29, 2009
Triage and management of accidental laboratory exposures to biosafety level-3 and -4 agentsPeter Jahrling, Colleen Rodak, Mike Bray, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2003
Aerosolized cidofovir is retained in the respiratory tract and protects mice against intranasal cowpox virus challengeChad J Roy, Robert Baker, Kenneth Washburn, et al.
Physiological Measurement|May 31, 2013
On the accuracy of instantaneous gas exchange rates, energy expenditure and respiratory quotient calculations obtained from indirect whole room calorimetryAndrei Gribok, Reed Hoyt, Mark Buller, et al.
Antiviral Research|June 22, 2002
3-deazaneplanocin A induces massively increased interferon-alpha production in Ebola virus-infected miceMike Bray, Jo Lynne Raymond, Tom Geisbert, et al.
Antiviral Research|April 25, 2020
Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responsesMike Bray, Craig Rayner, François Noël, et al.
Antiviral Research|March 18, 2004
A simple assay for determining antiviral activity against Crimean-Congo hemorrhagic fever virusJason Paragas, Chris A Whitehouse, Timothy P Endy, et al.
Antiviral Research|June 14, 2002
Treatment of aerosolized cowpox virus infection in mice with aerosolized cidofovirMike Bray, Mark Martinez, Deborah Kefauver, et al.
Pageof 14

Showing results (31-40 of 134) with videos related to

Sort By:
Pageof 14
Antiviral Research|March 5, 2003
Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infectionsRobert O Baker, Mike Bray, John W Huggins
Viruses|November 22, 2012
Mouse models for filovirus infectionsSteven B Bradfute, Kelly L Warfield, Mike Bray
Future Virology|September 4, 2009
Therapeutic and prophylactic drugs to treat orthopoxvirus infectionsScott Parker, Lauren Handley, R Mark Buller
Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science|July 29, 2009
Triage and management of accidental laboratory exposures to biosafety level-3 and -4 agentsPeter Jahrling, Colleen Rodak, Mike Bray, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2003
Aerosolized cidofovir is retained in the respiratory tract and protects mice against intranasal cowpox virus challengeChad J Roy, Robert Baker, Kenneth Washburn, et al.
Physiological Measurement|May 31, 2013
On the accuracy of instantaneous gas exchange rates, energy expenditure and respiratory quotient calculations obtained from indirect whole room calorimetryAndrei Gribok, Reed Hoyt, Mark Buller, et al.
Antiviral Research|June 22, 2002
3-deazaneplanocin A induces massively increased interferon-alpha production in Ebola virus-infected miceMike Bray, Jo Lynne Raymond, Tom Geisbert, et al.
Antiviral Research|April 25, 2020
Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responsesMike Bray, Craig Rayner, François Noël, et al.
Antiviral Research|March 18, 2004
A simple assay for determining antiviral activity against Crimean-Congo hemorrhagic fever virusJason Paragas, Chris A Whitehouse, Timothy P Endy, et al.
Antiviral Research|June 14, 2002
Treatment of aerosolized cowpox virus infection in mice with aerosolized cidofovirMike Bray, Mark Martinez, Deborah Kefauver, et al.
Pageof 14